Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by nemo3on Nov 29, 2019 2:47pm

117 Views

Post# 30406609

RE:RE:Is this TLT type liftoff after FDA IND approval?

I would suspect we will see a jump in TLT after the much anticipated FDA news release comes out. I also suspect that a jump will be somewhat muted by the number of shares out. When the time arrives that we get results of this Ph2 study and they meet or exceed expectations, it will be very interesting to see where TLT's share price goes. Even with stellar results, shares outstanding will affect the price. At 35 million shares, success could have meant a $50 share price or more. With the number we currently have, I would think the max we get out of this is $5. Maybe $10. Of course, I would like $100 but would think that is unrealistic again given OS. What are other's thoughts on this?

Bullboard Posts

Debt-free cannabis company set for next stage of growth